These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 25387157

  • 1. Outcomes of children younger than 24 months with langerhans cell histiocytosis and bone involvement: a report from a single institution.
    Kamath S, Arkader A, Jubran RF.
    J Pediatr Orthop; 2014 Dec; 34(8):825-30. PubMed ID: 25387157
    [Abstract] [Full Text] [Related]

  • 2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
    Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H.
    Klin Padiatr; 2000 Dec; 212(4):139-44. PubMed ID: 10994540
    [Abstract] [Full Text] [Related]

  • 3. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
    Davidson L, McComb JG, Bowen I, Krieger MD.
    J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
    [Abstract] [Full Text] [Related]

  • 4. Predictors of outcome in children with Langerhans cell histiocytosis.
    Jubran RF, Marachelian A, Dorey F, Malogolowkin M.
    Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
    [Abstract] [Full Text] [Related]

  • 5. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
    Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Melon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S.
    Orphanet J Rare Dis; 2017 May 22; 12(1):95. PubMed ID: 28532436
    [Abstract] [Full Text] [Related]

  • 6. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
    Mottl H, Ganevová M, Radvanská J, Chánová M, Smelhaus V, Kodet R, Mrhalová M, Tichý M.
    Cas Lek Cesk; 2005 May 22; 144(11):753-5. PubMed ID: 16335702
    [Abstract] [Full Text] [Related]

  • 7. Treatment strategy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group.
    Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S.
    Med Pediatr Oncol; 1994 May 22; 23(2):72-80. PubMed ID: 8202045
    [Abstract] [Full Text] [Related]

  • 8. Langerhans cell histiocytosis: clinical experience with 124 patients.
    Rivera-Luna R, Martinez-Guerra G, Altamirano-Alvarez E, Martinez-Avalos A, Cardenas-Cardoz R, Ayon-Cardenas A, Ruiz-Maldonado R, Lopez-Corella E.
    Pediatr Dermatol; 1988 Aug 22; 5(3):145-50. PubMed ID: 3264610
    [Abstract] [Full Text] [Related]

  • 9. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
    Morimoto A, Ishida Y, Suzuki N, Ohga S, Shioda Y, Okimoto Y, Kudo K, Ishii E, HLH/LCH Committee of the Japanese Society of Pediatric Hematology.
    Pediatr Blood Cancer; 2010 Jan 22; 54(1):98-102. PubMed ID: 19728332
    [Abstract] [Full Text] [Related]

  • 10. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
    Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C, Dijoud F, Rigau V, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Miron J, Jeziorski E, Plat G, Aladjidi N, Ferster A, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Armari-Alla C, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Lescoeur B, Gandemer V, Bodemer C, Lacave R, Hélias-Rodzewicz Z, Taly V, Geissmann F, Donadieu J.
    J Clin Oncol; 2016 Sep 01; 34(25):3023-30. PubMed ID: 27382093
    [Abstract] [Full Text] [Related]

  • 11. Langerhans cell histiocytosis of the temporal bone: A review of 29 cases at a single center.
    Modest MC, Garcia JJ, Arndt CS, Carlson ML.
    Laryngoscope; 2016 Aug 01; 126(8):1899-904. PubMed ID: 26535795
    [Abstract] [Full Text] [Related]

  • 12. Approaches to treatment of unifocal langerhans cell histiocytosis: is biopsy alone enough?
    Rivera JC, Wylie E, Dell'Orfano S, Mooney R, Hensley MA, Carry P, Monreal AK, Heare T.
    J Pediatr Orthop; 2014 Dec 01; 34(8):820-4. PubMed ID: 24590333
    [Abstract] [Full Text] [Related]

  • 13. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.
    Gadner H, Minkov M, Grois N, Pötschger U, Thiem E, Aricò M, Astigarraga I, Braier J, Donadieu J, Henter JI, Janka-Schaub G, McClain KL, Weitzman S, Windebank K, Ladisch S, Histiocyte Society.
    Blood; 2013 Jun 20; 121(25):5006-14. PubMed ID: 23589673
    [Abstract] [Full Text] [Related]

  • 14. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
    Giona F, Caruso R, Testi AM, Moleti ML, Malagnino F, Martelli M, Ruco L, Giannetti GP, Annibali S, Mandelli F.
    Cancer; 1997 Nov 01; 80(9):1786-91. PubMed ID: 9351548
    [Abstract] [Full Text] [Related]

  • 15. Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report.
    Mansour MJ, Mokbel E, Fares E, Maddah J, Nasr F.
    J Med Case Rep; 2017 Sep 25; 11(1):272. PubMed ID: 28942734
    [Abstract] [Full Text] [Related]

  • 16. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
    Minkov M.
    Paediatr Drugs; 2011 Apr 01; 13(2):75-86. PubMed ID: 21351807
    [Abstract] [Full Text] [Related]

  • 17. Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
    Tantawy AAG, Ragab IA, Elsherif NHK, Makkeyah SM, AbdelRaheem HG, Elsantiel HIE.
    Pediatr Hematol Oncol; 2020 Nov 01; 37(8):696-706. PubMed ID: 32706277
    [Abstract] [Full Text] [Related]

  • 18. Langerhans cell histiocytosis of skull: a retrospective study of 18 cases.
    Zhang XH, Zhang J, Chen ZH, Sai K, Chen YS, Wang J, Ke C, Guo CC, Chen ZP, Mou YG.
    Ann Palliat Med; 2017 Apr 01; 6(2):159-164. PubMed ID: 28061539
    [Abstract] [Full Text] [Related]

  • 19. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
    Lee JW, Shin HY, Kang HJ, Kim H, Park JD, Park KD, Kim HS, Park SH, Wang KC, Ahn HS.
    Pediatr Hematol Oncol; 2014 Apr 01; 31(3):293-302. PubMed ID: 24397251
    [Abstract] [Full Text] [Related]

  • 20. Outcome of children with Langerhans cell histiocytosis and single-system involvement: A retrospective study at a single center in Shanghai, China.
    Su M, Gao YJ, Pan C, Chen J, Tang JY.
    Pediatr Hematol Oncol; 2018 Apr 01; 35(7-8):385-392. PubMed ID: 30693828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.